US · guidance
CMS Pub. 100-04, ch. 17, § 20.1
MMA Drug Pricing - Average Sales Price
In general, CMS establishes a single, national payment limit for A/B MAC (A), A/B MAC (B), A/B
MAC (HHH) and DME MAC payment for each Medicare-covered drug whose payment is determined
based on the methodology described above. Drugs billed to DME MACs are still priced locally, albeit
under the new statutory formula, as applicable. The four DME MACs jointly establish drug payment
limits for drugs that are billed to DME MACs.
The CMS provides an ASP file to each MAC for pricing drugs. Each MAC must accept the ASP files
made available by CMS for pricing bills/claims for any drug identified on the price files.
The ASP drug pricing file shall contain 3 places after the decimal point in the currency field for the
ASP file and contractors shall load the ASP file including 3 places after the decimal point. Contractors
shall carry 3 places after the decimal point for the calculation of the amount due for a line item for each
covered drug, then follow standard rounding procedures in determining the final allowance for that line
item. The final allowed amounts will continue to carry 2 places after the decimal point.
The payment limits included in the revised ASP and Not Otherwise Classified (NOC) payment files
supersede the payment limits for these codes in any publication published prior to this document.
History
(Rev. 1513; Issued: 05-23-08; Effective/Implementation Date: 06-23-08)
Provenance
- Source
- cms.gov
- Retrieved
- 2026-08-25
- Edition
- iom-2026-08-25
- Content hash
c26acf3a277ea88991961e7cf33de254cb1aa5a652aead1fec8c1af5fbc3a3f4
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.